Hims & Hers Health Inc. drops 0.05% after Novo Nordisk ends collaboration-To The Moon - Tiger Brokers Online Investing Community - To The Moon

Like
Comment
Favorite

Hims & Hers Health Inc. drops 0.05% after Novo Nordisk ends collaboration

Market Watcher2025-06-24

June 23rd, 8:00 PM, after the US stock market opened, several stocks experienced significant movements.

Hims & Hers Health Inc. saw a slight decline of 0.05% in the night session, following the termination of its collaboration with Novo Nordisk.
Novo Nordisk, the maker of the weight-loss drug Wegovy, terminated its collaboration with Hims & Hers due to deceptive promotion and selling of knockoff versions of Wegovy. This decision led to a significant drop in Hims & Hers' stock price. The disagreement arose from allegations of patient safety risks and anticompetitive demands. Novo Nordisk's move followed the FDA's decision to end a drug-shortage declaration for weight-loss drugs, impacting the distribution of generics. The fallout between the two companies may have broader implications for the industry.

Today's Night Session Top 5 Gainers
iBio : +57.22%
Plus Therapeutics, Inc. : +41.07%
TuHURA Biosciences, Inc. : +18.97%
Digi Power X Inc. : +11.81%
Biodesix, Inc. : +10.31%

Today's Night Session Top 5 Decliners
Indonesia Energy Corp Ltd. : -24.85%
US Energy Corp : -23.37%
Houston American : -22.65%
EON RESOURCES INC : -20.83%
Barnwell : -20.00%

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Like

Report

Comment

empty

No comments yet

Most Discussed

7x24

{"i18n":{"language":"en_US"},"data":{"share":"https://ttm.financial/m/news/1121846475?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2025-06-24 08:10","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1121846475","market":"us","top_or_hot":-1,"title":"Hims & Hers Health Inc. drops 0.05% after Novo Nordisk ends collaboration","media":"Market Watcher","content":"June 23rd, 8:00 PM, after the US stock market opened, several stocks experienced significant movements.<br><br><b><a href=\"https://laohu8.com/S/HIMS\">Hims & Hers Health Inc. </a> saw a slight decline of 0.05% in the night session, following the termination of its collaboration with Novo Nordisk.</b><br>Novo Nordisk, the maker of the weight-loss drug Wegovy, terminated its collaboration with Hims & Hers due to deceptive promotion and selling of knockoff versions of Wegovy. This decision led to a significant drop in Hims & Hers' stock price. The disagreement arose from allegations of patient safety risks and anticompetitive demands. Novo Nordisk's move followed the FDA's decision to end a drug-shortage declaration for weight-loss drugs, impacting the distribution of generics. The fallout between the two companies may have broader implications for the industry.<br><br><b>Today's Night Session Top 5 Gainers</b><br><a href=\"https://laohu8.com/S/IBIO\">iBio </a>: +57.22%<br><a href=\"https://laohu8.com/S/PSTV\">Plus Therapeutics, Inc. </a>: +41.07%<br><a href=\"https://laohu8.com/S/HURA\">TuHURA Biosciences, Inc. </a>: +18.97%<br><a href=\"https://laohu8.com/S/DGXX\">Digi Power X Inc. </a>: +11.81%<br><a href=\"https://laohu8.com/S/BDSX\">Biodesix, Inc. </a>: +10.31%<br><br><b>Today's Night Session Top 5 Decliners</b><br><a href=\"https://laohu8.com/S/INDO\">Indonesia Energy Corp Ltd. </a>: -24.85%<br><a href=\"https://laohu8.com/S/USEG\">US Energy Corp </a>: -23.37%<br><a href=\"https://laohu8.com/S/HUSA\">Houston American </a>: -22.65%<br><a href=\"https://laohu8.com/S/EONR\">EON RESOURCES INC </a>: -20.83%<br><a href=\"https://laohu8.com/S/BRN\">Barnwell </a>: -20.00%","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Hims & Hers Health Inc. drops 0.05% after Novo Nordisk ends collaboration</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nHims & Hers Health Inc. drops 0.05% after Novo Nordisk ends collaboration\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1027265475\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/b4070558872429328fe9f26a97b36c72);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Market Watcher </p>\n<p class=\"h-time\">2025-06-24 08:10</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\nJune 23rd, 8:00 PM, after the US stock market opened, several stocks experienced significant movements.<br><br><b><a href=\"https://laohu8.com/S/HIMS\">Hims & Hers Health Inc. </a> saw a slight decline of 0.05% in the night session, following the termination of its collaboration with Novo Nordisk.</b><br>Novo Nordisk, the maker of the weight-loss drug Wegovy, terminated its collaboration with Hims & Hers due to deceptive promotion and selling of knockoff versions of Wegovy. This decision led to a significant drop in Hims & Hers' stock price. The disagreement arose from allegations of patient safety risks and anticompetitive demands. Novo Nordisk's move followed the FDA's decision to end a drug-shortage declaration for weight-loss drugs, impacting the distribution of generics. The fallout between the two companies may have broader implications for the industry.<br><br><b>Today's Night Session Top 5 Gainers</b><br><a href=\"https://laohu8.com/S/IBIO\">iBio </a>: +57.22%<br><a href=\"https://laohu8.com/S/PSTV\">Plus Therapeutics, Inc. </a>: +41.07%<br><a href=\"https://laohu8.com/S/HURA\">TuHURA Biosciences, Inc. </a>: +18.97%<br><a href=\"https://laohu8.com/S/DGXX\">Digi Power X Inc. </a>: +11.81%<br><a href=\"https://laohu8.com/S/BDSX\">Biodesix, Inc. </a>: +10.31%<br><br><b>Today's Night Session Top 5 Decliners</b><br><a href=\"https://laohu8.com/S/INDO\">Indonesia Energy Corp Ltd. </a>: -24.85%<br><a href=\"https://laohu8.com/S/USEG\">US Energy Corp </a>: -23.37%<br><a href=\"https://laohu8.com/S/HUSA\">Houston American </a>: -22.65%<br><a href=\"https://laohu8.com/S/EONR\">EON RESOURCES INC </a>: -20.83%<br><a href=\"https://laohu8.com/S/BRN\">Barnwell </a>: -20.00%\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":".DJI","symbol_name":"道琼斯","start_time":0,"source_url":"","article_id":"1121846475","we_media_id":"1027265475","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1121846475","pubTimestamp":1750723814,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Market Watcher","introduction":"stay tuned on realtime market movements","home_visible":1,"id":"1027265475","head_image":"https://static.tigerbbs.com/b4070558872429328fe9f26a97b36c72"},"summary":"June 23rd, 8:00 PM, after the US stock market opened, several stocks experienced significant movements.$Hims & Hers Health Inc. $ saw a slight decline of 0.05% in the night session, following the termination of its collaboration with Novo Nordisk.Novo Nordisk, the maker of the weight-loss drug Wegovy, terminated its collaboration with Hims & Hers due to deceptive promotion and selling of knockoff versions of Wegovy. This decision led to a significant drop in Hims & Hers' stock price. The disagre","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{".DJI":"道琼斯",".IXIC":"NASDAQ Composite",".SPX":"S&P 500 Index"},"translate_title":"诺和诺德终止合作后Hims&Hers Health Inc.股价下跌0.05%","themeId":"8e530ee89fa0c32e19960250bff44e7b","isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{".IXIC":1,".DJI":1,".SPX":1},"content_text":"June 23rd, 8:00 PM, after the US stock market opened, several stocks experienced significant movements.Hims & Hers Health Inc.  saw a slight decline of 0.05% in the night session, following the termination of its collaboration with Novo Nordisk.Novo Nordisk, the maker of the weight-loss drug Wegovy, terminated its collaboration with Hims & Hers due to deceptive promotion and selling of knockoff versions of Wegovy. This decision led to a significant drop in Hims & Hers' stock price. The disagreement arose from allegations of patient safety risks and anticompetitive demands. Novo Nordisk's move followed the FDA's decision to end a drug-shortage declaration for weight-loss drugs, impacting the distribution of generics. The fallout between the two companies may have broader implications for the industry.Today's Night Session Top 5 GainersiBio : +57.22%Plus Therapeutics, Inc. : +41.07%TuHURA Biosciences, Inc. : +18.97%Digi Power X Inc. : +11.81%Biodesix, Inc. : +10.31%Today's Night Session Top 5 DeclinersIndonesia Energy Corp Ltd. : -24.85%US Energy Corp : -23.37%Houston American : -22.65%EON RESOURCES INC : -20.83%Barnwell : -20.00%","kind":"news","is_publish_news":false,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"-1","news_tag":"","news_rank":0,"symbols":[],"gpt_button":0,"need_auth":false,"code":"91000000","status":"200"},"commentList":[],"hasMoreComments":false,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"isCrawlerRequest":true}